Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease
- 1 October 1998
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 28 (10) , 1244-1250
- https://doi.org/10.1046/j.1365-2222.1998.00342.x
Abstract
Background: Nitric oxide (NO) plays an important role as an inflammatory mediator in the airways. Though direct measurement of endogenous NO has been difficult in humans, we have recently found that measurement of NO derivatives in induced sputum may be useful for assessing airway inflammation in asthmatic patients.Objective: This study was designed to determine the direct in vivo evidence of increased production of endogenous NO in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD).Methods: We have investigated simultaneous assessment of NO using two non‐invasive methods, such as NO level in exhaled air and induced sputum, in these patients. We determined the concentration of stable end‐products of NO (nitrite plus nitrate) in induced sputum and exhaled NO concentration using a chemiluminescence analyser in 10 normal controls, 10 asthmatic patients and 11 patients with COPD, and evaluated whether endogenous NO levels correlate with percentage of neutrophils and interleukin‐8 (IL‐8) level in induced sputum in patients with COPD.Results: We found significantly higher concentrations of exhaled NO in patients with bronchial asthma (25.1 [5.1] p.p.b.) than in patients with COPD (12.1 [1.9] p.p.b.) and normal controls (5.2 [1.4] p.p.b.). However, higher concentrations of NO derivatives in induced sputum were found in patients with bronchial asthma (1190 [106] μmol/L) and COPD (950 [105] μmol/L) than in normal controls (514 [30] μmol/L). In patients with asthma, but not in those with COPD, concentrations of NO derivatives in induced sputum were significantly correlated with concentrations of exhaled NO (r = 0.64, P < 0.05). Moreover, in patients with COPD, concentrations of NO derivatives in induced sputum were significantly correlated with percentage of neutrophils (r = 0.71, P < 0.05) and IL‐8 level (r = 0.80, P < 0.01).Conclusion: We conclude the increased production of endogenous NO in patients with asthma and COPD, and that NO derivatives in induced sputum are more valuable than exhaled NO in assessing airway inflammation in patients with COPD.Keywords
This publication has 22 references indexed in Scilit:
- Role of Endogenous Nitric Oxide in Airflow Obstruction in SmokersChest, 1996
- Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.Thorax, 1996
- Clinical Significance of Serum Concentration of lnterleukin-8 in Patients with Bronchial Asthma or Chronic Pulmonary EmphysemaRespiration, 1996
- Increased nitric oxide in exhaled air of asthmatic patientsPublished by Elsevier ,1994
- Induction of nitric oxide synthase in asthmaThe Lancet, 1993
- Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humansBiochemical and Biophysical Research Communications, 1991
- The value of mucus hypersecretion as a predictor of mortality and hospitalization. An 11-year register based follow-up study of a random population sample of 876 menRespiratory Medicine, 1989
- A novel neutrophil-activating factor produced by human mononuclear phagocytes.The Journal of Experimental Medicine, 1988
- Eosinophils and Mast Cells in Bronchoalveolar Lavage in Subjects with Mild Asthma: Relationship to Bronchial HyperreactivityAmerican Review of Respiratory Disease, 1988
- Association between Nonspecific Bronchial Hyperreactivity and Superoxide Anion Production by Polymorphonuclear Leukocytes in Chronic Air-Flow ObstructionAmerican Review of Respiratory Disease, 1988